Company intelligence / Profile preview

ProCore Bio

Suzhou, Jiangsu, China

Ownership: Private
Employees: ~100
Development stage: Other

Overview

ProCore Bio-Med is a biotechnology company specializing in the development and manufacture of high-quality recombinant proteins, cytokines, and enzymes for the cell and gene therapy (CGT) industry. Based in Suzhou, China, the company provides GMP-grade raw materials such as IL-2, IL-7, and IL-15, which are essential for the expansion and differentiation of immune cells. ProCore Bio-Med leverages its proprietary protein expression and purification platforms to ensure high bioactivity, purity, and consistency across its product lines. The company serves global biopharmaceutical firms and research institutions, supporting the advancement of regenerative medicine and immunotherapy.

Therapeutic areas: OncologyImmunologyOther
Modalities: Recombinant proteinCytokineEnzyme
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on ProCore Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ProCore Bio.

Explore the full profile